These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 28582388
21. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus. Chaudhury S, Gromowski GD, Ripoll DR, Khavrutskii IV, Desai V, Wallqvist A. PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130 [Abstract] [Full Text] [Related]
24. The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides. Anandarao R, Swaminathan S, Khanna N. Virus Res; 2005 Sep; 112(1-2):60-8. PubMed ID: 16022901 [Abstract] [Full Text] [Related]
28. A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients. Omokoko MD, Pambudi S, Phanthanawiboon S, Masrinoul P, Setthapramote C, Sasaki T, Kuhara M, Ramasoota P, Yamashita A, Hirai I, Ikuta K, Kurosu T. Am J Trop Med Hyg; 2014 Jul; 91(1):146-55. PubMed ID: 24778195 [Abstract] [Full Text] [Related]
29. Natural strain variation and antibody neutralization of dengue serotype 3 viruses. Wahala WM, Donaldson EF, de Alwis R, Accavitti-Loper MA, Baric RS, de Silva AM. PLoS Pathog; 2010 Mar 19; 6(3):e1000821. PubMed ID: 20333252 [Abstract] [Full Text] [Related]
31. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity. Lau L, Green AM, Balmaseda A, Harris E. J Clin Virol; 2015 Aug 19; 69():63-7. PubMed ID: 26209381 [Abstract] [Full Text] [Related]
33. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay. Hadjilaou A, Green AM, Coloma J, Harris E. J Immunol; 2015 Oct 01; 195(7):3490-6. PubMed ID: 26320246 [Abstract] [Full Text] [Related]
34. Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue. Keasey SL, Smith JL, Fernandez S, Durbin AP, Zhao BM, Ulrich RG. ACS Infect Dis; 2018 Dec 14; 4(12):1705-1717. PubMed ID: 30347144 [Abstract] [Full Text] [Related]
36. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections. Gallichotte EN, Baric RS, de Silva AM. Adv Exp Med Biol; 2018 Dec 14; 1062():63-76. PubMed ID: 29845525 [Abstract] [Full Text] [Related]
37. Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Jiang L, Zhou JM, Yin Y, Fang DY, Tang YX, Jiang LF. Virus Res; 2010 Jun 14; 150(1-2):49-55. PubMed ID: 20211209 [Abstract] [Full Text] [Related]
38. Antibody affinity versus dengue morphology influences neutralization. Fibriansah G, Lim EXY, Marzinek JK, Ng TS, Tan JL, Huber RG, Lim XN, Chew VSY, Kostyuchenko VA, Shi J, Anand GS, Bond PJ, Crowe JE, Lok SM. PLoS Pathog; 2021 Feb 14; 17(2):e1009331. PubMed ID: 33621239 [Abstract] [Full Text] [Related]
40. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen. Alves RPDS, Pereira LR, Fabris DLN, Salvador FS, Santos RA, Zanotto PMA, Romano CM, Amorim JH, Ferreira LCS. Clin Vaccine Immunol; 2016 Jun 14; 23(6):460-469. PubMed ID: 27030586 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]